Arginine Malaria Trial: Study of Adjunctive Arginine in Falciparum Malaria

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

April 30, 2006

Study Completion Date

December 31, 2007

Conditions
Malaria, Falciparum
Interventions
DRUG

intravenous (IV) arginine

Trial Locations (1)

Unknown

RSMM Hospital, Timika

All Listed Sponsors
collaborator

Wellcome Trust

OTHER

collaborator

National Health and Medical Research Council, Australia

OTHER

collaborator

MSHR

UNKNOWN

collaborator

National Institute of Health Research and Development, Ministry of Health Republic of Indonesia

OTHER

collaborator

Rumah Sakit Mitra Masyarakat Hospital

OTHER

collaborator

University of Utah

OTHER

collaborator

University of Sydney

OTHER

lead

Menzies School of Health Research

OTHER

NCT00147368 - Arginine Malaria Trial: Study of Adjunctive Arginine in Falciparum Malaria | Biotech Hunter | Biotech Hunter